128 related articles for article (PubMed ID: 30446846)
1. CDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitor.
Phyu SM; Tseng CC; Smith TAD
MAGMA; 2019 Apr; 32(2):227-235. PubMed ID: 30446846
[TBL] [Abstract][Full Text] [Related]
2. Choline derived from the phosphatidylcholine specific phospholipase D is not directly available for the CDP choline pathway in phorbol ester-treated C3H10T1/2 Cl 8 fibroblasts.
Thorsen VA; Bruland O; Lillehaug JR; Holmsen H
Mol Cell Biochem; 1998 Oct; 187(1-2):147-54. PubMed ID: 9788752
[TBL] [Abstract][Full Text] [Related]
3. Involvement of CDP-choline in phospholipid metabolism of brain tissue in vitro.
Arienti G; Corazzi L; Mastrofini P; Montanini I; Tirillini B; Porcellati G
Ital J Biochem; 1979; 28(1):39-45. PubMed ID: 553079
[TBL] [Abstract][Full Text] [Related]
4. Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase.
MacAulay K; Hajduch E; Blair AS; Coghlan MP; Smith SA; Hundal HS
Eur J Biochem; 2003 Sep; 270(18):3829-38. PubMed ID: 12950267
[TBL] [Abstract][Full Text] [Related]
5. Choline turnover in phosphatidylcholine of pancreatic islets. Implications for CDP-choline pathway.
Hoffman JM; Laychock SG
Diabetes; 1988 Nov; 37(11):1489-98. PubMed ID: 2846391
[TBL] [Abstract][Full Text] [Related]
6. Metformin Decouples Phospholipid Metabolism in Breast Cancer Cells.
Smith TA; Phyu SM
PLoS One; 2016; 11(3):e0151179. PubMed ID: 26959405
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase 3 (GSK3)-inhibitor SB216763 promotes the conversion of human umbilical cord mesenchymal stem cells into neural precursors in adherent culture.
Gao L; Zhao M; Li P; Kong J; Liu Z; Chen Y; Huang R; Chu J; Quan J; Zeng R
Hum Cell; 2017 Jan; 30(1):11-22. PubMed ID: 27604750
[TBL] [Abstract][Full Text] [Related]
9. Lenticular cytoprotection, part 2: link between glycogen synthase kinase-3β, epithelial to mesenchymal transition, and mitochondrial depolarization.
Neelam S; Brooks MM; Cammarata PR
Mol Vis; 2014; 20():1758-75. PubMed ID: 25593505
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells.
Tan J; Zhuang L; Leong HS; Iyer NG; Liu ET; Yu Q
Cancer Res; 2005 Oct; 65(19):9012-20. PubMed ID: 16204075
[TBL] [Abstract][Full Text] [Related]
11. The glycogen synthase kinase inhibitor 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) is a partial agonist of the aryl hydrocarbon receptor.
Braeuning A; Buchmann A
Drug Metab Dispos; 2009 Aug; 37(8):1576-80. PubMed ID: 19448134
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylcholine metabolism in nuclei of phorbol ester-activated LA-N-1 neuroblastoma cells.
Antony P; Kanfer JN; Freysz L
Neurochem Res; 2000 Aug; 25(8):1073-82. PubMed ID: 11055744
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase 3 regulates IL-1β mediated iNOS expression in hepatocytes by down-regulating c-Jun.
Lakshmanan J; Zhang B; Nweze IC; Du Y; Harbrecht BG
J Cell Biochem; 2015 Jan; 116(1):133-41. PubMed ID: 25160751
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase 3-β: a master regulator of toll-like receptor-mediated chronic intestinal inflammation.
Hofmann C; Dunger N; Schölmerich J; Falk W; Obermeier F
Inflamm Bowel Dis; 2010 Nov; 16(11):1850-8. PubMed ID: 20848477
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of CDP-choline on brain cytosolic choline levels in younger and older subjects as measured by proton magnetic resonance spectroscopy.
Babb SM; Appelmans KE; Renshaw PF; Wurtman RJ; Cohen BM
Psychopharmacology (Berl); 1996 Sep; 127(2):88-94. PubMed ID: 8888372
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms.
Marchand B; Tremblay I; Cagnol S; Boucher MJ
Carcinogenesis; 2012 Mar; 33(3):529-37. PubMed ID: 22201186
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of CDP-choline synthesis by uridine or cytidine in PC12 rat pheochromocytoma cells.
Richardson UI; Watkins CJ; Pierre C; Ulus IH; Wurtman RJ
Brain Res; 2003 May; 971(2):161-7. PubMed ID: 12706232
[TBL] [Abstract][Full Text] [Related]
18. Functional redundancy of CDP-ethanolamine and CDP-choline pathway enzymes in phospholipid biosynthesis: ethanolamine-dependent effects on steady-state membrane phospholipid composition in Saccharomyces cerevisiae.
McGee TP; Skinner HB; Bankaitis VA
J Bacteriol; 1994 Nov; 176(22):6861-8. PubMed ID: 7961445
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
20. Effect of exogenous CDP-choline on choline metabolism in isolated adult rat ventricular myocytes under normoxic and hypoxic conditions.
Rabkin SW
Cell Biochem Funct; 1993 Jun; 11(2):137-43. PubMed ID: 8324883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
